» Articles » PMID: 31147553

Paediatric and Adult-onset Male Hypogonadism

Abstract

The hypothalamic-pituitary-gonadal axis is of relevance in many processes related to the development, maturation and ageing of the male. Through this axis, a cascade of coordinated activities is carried out leading to sustained testicular endocrine function, with gonadal testosterone production, as well as exocrine function, with spermatogenesis. Conditions impairing the hypothalamic-pituitary-gonadal axis during paediatric or pubertal life may result in delayed puberty. Late-onset hypogonadism is a clinical condition in the ageing male combining low concentrations of circulating testosterone and specific symptoms associated with impaired hormone production. Testosterone therapy for congenital forms of hypogonadism must be lifelong, whereas testosterone treatment of late-onset hypogonadism remains a matter of debate because of unclear indications for replacement, uncertain efficacy and potential risks. This Primer focuses on a reappraisal of the physiological role of testosterone, with emphasis on the critical interpretation of the hypogonadal conditions throughout the lifespan of the male individual, with the exception of hypogonadal states resulting from congenital disorders of sex development.

Citing Articles

Association between the oxidative balance score and testosterone deficiency: a cross-sectional study of the NHANES, 2011-2016.

Liu J, Ma C, Leng Y, Qin J, Zhang P Sci Rep. 2025; 15(1):8040.

PMID: 40055483 PMC: 11889201. DOI: 10.1038/s41598-025-92934-5.


Age-related decline in total testosterone levels among young men: insights from a large single-center observational study.

Corsini C, Pozzi E, Belladelli F, Bertini A, Negri F, Raffo M Int J Impot Res. 2025; .

PMID: 39987403 DOI: 10.1038/s41443-025-01029-2.


Association of total testosterone levels with cardiometabolic diseases in men with erectile dysfunction.

Chen B, Tsai P, Jiann B Sex Med. 2025; 12(6):qfae089.

PMID: 39801930 PMC: 11723798. DOI: 10.1093/sexmed/qfae089.


Is There a Role for Hormonal Therapy in Men with Oligoasthenoteratozoospermia (OAT)?.

Cayan S, Altay A, Rambhatla A, Colpi G, Agarwal A J Clin Med. 2025; 14(1.

PMID: 39797269 PMC: 11721639. DOI: 10.3390/jcm14010185.


MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility.

Chico-Sordo L, Garcia-Velasco J Int J Mol Sci. 2024; 25(23.

PMID: 39684688 PMC: 11640832. DOI: 10.3390/ijms252312979.


References
1.
Jasuja G, Bhasin S, Reisman J, Berlowitz D, Rose A . Ascertainment of Testosterone Prescribing Practices in the VA. Med Care. 2015; 53(9):746-52. DOI: 10.1097/MLR.0000000000000398. View

2.
Pierzchlewska M, Robaczyk M, Vogel I . Induction of puberty with human chorionic gonadotropin (hCG) followed by reversal of hypogonadotropic hypogonadism in Kallmann syndrome. Endokrynol Pol. 2017; 68(6):692-696. DOI: 10.5603/EP.a2017.0059. View

3.
Grinspon R, Ropelato M, Bedecarras P, Loreti N, Ballerini M, Gottlieb S . Gonadotrophin secretion pattern in anorchid boys from birth to pubertal age: pathophysiological aspects and diagnostic usefulness. Clin Endocrinol (Oxf). 2011; 76(5):698-705. DOI: 10.1111/j.1365-2265.2011.04297.x. View

4.
Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes F, Hughes V . Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007; 357(9):863-73. DOI: 10.1056/NEJMoa066494. View

5.
Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A . Sexual dysfunction in subjects with Klinefelter's syndrome. Int J Androl. 2009; 33(4):574-80. DOI: 10.1111/j.1365-2605.2009.00986.x. View